Cardioprotective aspirin--update on three previous special alerts.
Wynn
Richard L
RL
Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, MD, USA.
D001241:Aspirin / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000601:surgery; D054855:Drug-Eluting Stents; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020011:Protective Agents / Q000627:therapeutic use; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014652:Vascular Diseases / Q000517:prevention & control*
D010975:Platelet Aggregation Inhibitors; D020011:Protective Agents; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D007052:Ibuprofen